Sino Biological

Beijing, China Founded: 2007 • Age: 19 yrs
Reagents and kits are provided for clinical research applications.
Request Access

About Sino Biological

Sino Biological is a company based in Beijing (China) founded in 2007.. Sino Biological has raised $29.41 million across 1 funding round from investors including Qiming Venture Partners. Sino Biological has completed 1 acquisition, including SignalChem. Sino Biological operates in a competitive market with competitors including Abcam, GenScript, Stem Cell Technologies, Miltenyi Biotec and Devyser, among others.

  • Headquarter Beijing, China
  • Sectors
    Healthcare
  • Email
    ***********
  • Phone
    *********
  • Website
    *********
  • Social
    *********
Operational Areas
Healthcare → Biotechnology, Genomics & Life Sciences Research
Healthcare → Biotechnology, Genomics & Life Sciences Research
Key Metrics
  • Annual Revenue
  • Net Profit
  • EBITDA
  • Total Equity Funding
    $29.41 M (USD)

    in 1 rounds

  • Latest Funding Round
    $29.41 M (USD), Series A

    Jul 06, 2017

  • Investors
  • Employee Count
    Employee Count
  • Investments & Acquisitions
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal
People of Sino Biological
Headcount 200-500
Employee Profiles 35
Employee Profiles
People
Amia Spates
Associate Manager, Business Administration
People
Brett Werner
Account Executive
People
Yunhua(Andy) Liu Ph.D
Senior Account Manager / Business Development
People
Yi Ou
Regional Sales Manager

Unlock access to complete

Funding Insights of Sino Biological

Sino Biological has successfully raised a total of $29.41M through 1 strategic funding round. The most recent funding activity was a Series A round of $29.41 million completed in July 2017. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding
  • Total Rounds 1
  • Last Round Series A — $29.4M
  • First Round

    (06 Jul 2017)

  • Investors Count 1
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2017 Amount Series A - Sino Biological Valuation

investors

Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investors in Sino Biological

Sino Biological has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include Qiming Venture Partners. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.

All
Venture Fund
Investor Description Founded Year Domain Location
Venture capital investments are directed toward multiple sectors.
Founded Year Domain Location
Investor Description Founded Year Domain Location
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
Founded Year Domain Location
Startup ecosystems are ignited through strategic investments by Signite Partners.
Founded Year Domain Location
Venture capital is directed toward companies in multiple sectors.
Founded Year Domain Location
Venture capital is invested in cybersecurity, fintech, and AI startups.
Founded Year Domain Location

Investments & Acquisitions by Sino Biological

Sino Biological has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include SignalChem. These strategic investments and acquisitions demonstrate the company's commitment to growth through portfolio expansion, market consolidation, technology integration, and strategic partnerships that enhance competitive positioning and drive long-term value creation.

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Acquisitions
Company Name Description Domain Location Founded Year Amount
Develops products for Cell signaling research
2004
Company Name Description Domain Location Founded Year Amount
OVO is recognized as a smart digital payment application.
2017
Bionic investment advisor platform
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014

Financial Statements - Sino Biological

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Sino Biological Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of Sino Biological

Sino Biological operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Abcam, GenScript, Stem Cell Technologies, Miltenyi Biotec and Devyser, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Biological reagents and antibodies are developed for life science research.
domain founded_year HQ Location
Reagents and instruments are provided for life sciences research.
domain founded_year HQ Location
Developer of cell culture media and ancillary reagents for life science research
domain founded_year HQ Location
Develops tools and products for research and clinical application
domain founded_year HQ Location
Provider of molecular diagnostic kits for cancer, hereditary diseases, and reproductive disorders
Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Latest news on Sino Biological

Frequently Asked Questions about Sino Biological

When was Sino Biological founded?

Sino Biological was founded in 2007 and raised its 1st funding round 10 years after it was founded.

Where is Sino Biological located?

Sino Biological is headquartered in Beijing, China.

Is Sino Biological a funded company?

Sino Biological is a funded company, having raised a total of $29.41M across 1 funding round to date. The company's 1st funding round was a Series A of $29.41M, raised on Jul 06, 2017.

What does Sino Biological do?

Sino Biological was established in 2007 in Beijing, China, within the biotechnology sector. Recombinant proteins, antibodies, and antibody-based kits are supplied for examining cellular functions and human diseases. Custom services in antibody development, protein production, and purification are also extended to support research operations. The companys domain, sinobiological.com, facilitates access to these resources globally.

Who are the top competitors of Sino Biological?

Sino Biological's top competitors include Abcam, Meridian Bioscience and GenScript.

How many acquisitions has Sino Biological made?

Sino Biological has made 1 acquisition, including SignalChem.

Who are Sino Biological's investors?

Sino Biological has 1 investor. Key investors include Qiming Venture Partners.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available